Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunotherapeutics for Tuberculosis in Experimental Animals: Is There a Common Pathway Activated by Effective Protocols?

18 Jun 2007

Abstract excerpt

The increasing threat posed by drug-resistant strains of M. tuberculosis is leading to a reappraisal of the possibility of treating tuberculosis (TB) by immunotherapy. We analyze 6 strategies that have been shown to be therapeutic in animal models of TB and identify a common pathway underlying the activity of the superficially different immunotherapeutic protocols. This pathway involves enhanced induction of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Immune Response and Inflammation
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17570105
DOI: 10.1086/518937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapeutics for Tuberculosis in Experimental Animals: Is There a Common Pathway Activated by Effective Protocols?PMID 17570105Read ↗

The current state of animal models and genomic approaches towards identifying and validating molecular determinants ofMycobacterium tuberculosisinfection and tuberculosis diseaseSemantic proximity Read ↗

Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?Semantic proximity Read ↗

To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?Semantic proximity Read ↗

Host-directed therapies offer novel opportunities for the fight against tuberculosisSemantic proximity Read ↗

Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.Semantic proximity Read ↗

Host-directed therapy in the treatment of tuberculosisSemantic proximity Read ↗

Inflammation and tuberculosis: host‐directed therapiesSemantic proximity Read ↗

I <scp>mmunity to</scp> T <scp>uberculosis</scp>Semantic proximity Read ↗

Colony-stimulating factor-1- and interleukin-34-derived macrophages differ in their susceptibility to Mycobacterium marinumSemantic proximity Read ↗

Antibiotic treatment modestly reduces protection against Mycobacterium tuberculosis reinfection in macaquesSemantic proximity Read ↗

<scp>TB</scp> drug development: immunology at the tableSemantic proximity Read ↗

Interleukin-1 receptor antagonist is a conserved early factor for exacerbating tuberculosis susceptibilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.